A Study of the Cardiac Effects of ALXN2050 in Healthy Adults
Clinical trial NCT04660890 · COMPLETED
Trial details
- NCT number
- NCT04660890
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-12
- Primary completion
- 2021-03-16
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.